The Enterprise Value as of December 2025 (TTM) for OS Therapies Incorporated (OSTX) is -1812535881.00

According to OS Therapies Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is -1812535881.00. This represents a change of 499.40% compared to the average of -302389937.25 of the last 4 quarters.

OS Therapies Incorporated (OSTX) Historical Enterprise Value (quarterly & annually)

How has OSTX Enterprise Value performed in the past?

The mean historical Enterprise Value of OS Therapies Incorporated over the last ten years is 62.74M. The current -1812535881.00 Enterprise Value has changed -289016.91% with respect to the historical average. Over the past ten years (40 quarters), OSTX's Enterprise Value was at its highest in in the December 2024 quarter at 530.26M. The Enterprise Value was at its lowest in in the September 2025 quarter at -1813990895.44.

OS Therapies Incorporated (OSTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OS Therapies Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OS Therapies Incorporated (OSTX) Average Enterprise Value

How has OSTX Enterprise Value performed in the past?

The current Enterprise Value of OS Therapies Incorporated (OSTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

OS Therapies Incorporated (OSTX) Enterprise Value vs. Peers

How is OSTX’s Enterprise Value compared to its peers?

OS Therapies Incorporated’s Enterprise Value is less than Spruce Biosciences, Inc. (37.92M), less than Werewolf Therapeutics, Inc. (-8613546.00), less than Outlook Therapeutics, Inc. (117.30M), less than IO Biotech, Inc. (19.58M), less than CervoMed Inc. (75.51M), greater than MiNK Therapeutics, Inc. (-14223239186.00), less than Equillium, Inc. (-1382527.00), less than Coeptis Therapeutics, Inc. (52.89M), less than Adagene Inc. (18.30M), less than NRx Pharmaceuticals, Inc. (35.34M),

Build a custom stock screener for OS Therapies Incorporated (OSTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OS Therapies Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OS Therapies Incorporated (OSTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OS Therapies Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.